S Elad

68PUBLICATIONS
488CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAnimal systematics and taxonomyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Jul 31, 2026
Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Report from the 34th Acute Disease Quality Initiative (ADQI) Consensus Conference.

|Jun 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

|Jun 23, 2026
Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

|Jun 08, 2026
Cancer Chemoimmunotherapy: Time Will Tell.

|Apr 18, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

|Apr 17, 2026
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: vaginal cancer sub cohort results.

Pageof 12

Frequent Collaborators

8 joint publications

Megan Othus

7 joint publications

Razelle Kurzrock

6 joint publications

Abdul Rafeh Naqash

6 joint publications

Young Kwang Chae